Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-10

Clinical Trial Update: ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure" [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oral enoximone therapy for advanced heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enoximone (enoximone)

Snippet

Sponsor: Gilead Sciences | Conditions: Heart Failure, Congestive | Phase 3 | Status: TERMINATED